These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 12497870)

  • 21. Genetic polymorphisms in the renin-angiotensin system confer increased risk of stroke independently of blood pressure: a nested case-control study.
    Möllsten A; Stegmayr B; Wiklund PG
    J Hypertens; 2008 Jul; 26(7):1367-72. PubMed ID: 18551012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No effect of polymorphisms in prothrombotic genes on the risk of myocardial infarction in young adults without cardiovascular risk factors.
    Martini CH; Doggen CJ; Cavallini C; Rosendaal FR; Mannucci PM
    J Thromb Haemost; 2005 Jan; 3(1):177-9. PubMed ID: 15634285
    [No Abstract]   [Full Text] [Related]  

  • 23. Getting to grips with complexity of disease will make genomics useful in arterial thrombosis.
    Ariëns RA
    J Thromb Haemost; 2007 Mar; 5(3):450-3. PubMed ID: 17229045
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical impact of adducin polymorphism.
    Bianchi G; Manunta P; Glorioso N
    J Hypertens; 2009 Jun; 27(6):1325-7; author reply 1327-9. PubMed ID: 19454906
    [No Abstract]   [Full Text] [Related]  

  • 25. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.
    Kim RJ; Becker RC
    Am Heart J; 2003 Dec; 146(6):948-57. PubMed ID: 14660985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of coronary events in patients with hypertension.
    Wahlstrand B; Orho-Melander M; Delling L; Kjeldsen S; Narkiewicz K; Almgren P; Hedner T; Melander O
    J Hypertens; 2009 Apr; 27(4):769-73. PubMed ID: 19293724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [C825T polymorphism of the GNB3 gene codifying the G-protein beta3-subunit and cardiovascular risk].
    Sartori M; Parotto E; Ceolotto G; Papparella I; Lenzini L; Calò LA; Semplicini A
    Ann Ital Med Int; 2004; 19(4):240-8. PubMed ID: 15678704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic lupus erythematosus in a multiethnic US cohort: XXXIV. Deficient mannose-binding lectin exon 1 polymorphisms are associated with cerebrovascular but not with other arterial thrombotic events.
    Calvo-Alén J; Alarcón GS; Tew MB; Tan FK; McGwin G; Fessler BJ; Vilá LM; Reveille JD;
    Arthritis Rheum; 2006 Jun; 54(6):1940-5. PubMed ID: 16729310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of genetic and cardiovascular risk factors on the CADASIL phenotype.
    Singhal S; Bevan S; Barrick T; Rich P; Markus HS
    Brain; 2004 Sep; 127(Pt 9):2031-8. PubMed ID: 15229130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The genetics of multifactorial cardiovascular disease. How significant for the cardiologist?].
    Bauters C; Lamblin N; Amouyel P
    Arch Mal Coeur Vaiss; 2003 Nov; 96(11):1127-30. PubMed ID: 14694791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial nitric oxide synthase polymorphisms are associated with hypertension and cardiovascular disease in renal transplantation.
    Bhandary UV; Tse W; Yang B; Knowles MR; Demaine AG
    Nephrology (Carlton); 2008 Jun; 13(4):348-55. PubMed ID: 18331440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease.
    Lio D; Candore G; Crivello A; Scola L; Colonna-Romano G; Cavallone L; Hoffmann E; Caruso M; Licastro F; Caldarera CM; Branzi A; Franceschi C; Caruso C
    J Med Genet; 2004 Oct; 41(10):790-4. PubMed ID: 15466015
    [No Abstract]   [Full Text] [Related]  

  • 33. Genetic polymorphisms that predict outcome and need for treatment in cardiovascular disease.
    Yende S; Wunderink RG
    Curr Opin Crit Care; 2006 Oct; 12(5):420-5. PubMed ID: 16943719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Monogenic heart disease].
    Schönberger J; Ertl G
    Med Klin (Munich); 2008 Mar; 103(3):166-74. PubMed ID: 18344067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiplex amplification refractory mutation system for the detection of prothrombotic polymorphisms.
    Stirling D
    Methods Mol Biol; 2003; 226():323-6. PubMed ID: 12958516
    [No Abstract]   [Full Text] [Related]  

  • 36. [Genetics in cardiology].
    Brunecký Z
    Vnitr Lek; 1980 Jun; 26(6):610-9. PubMed ID: 7405025
    [No Abstract]   [Full Text] [Related]  

  • 37. Fibrinogen polymorphisms and disease.
    Laffan MA
    Eur Heart J; 2001 Dec; 22(24):2224-6. PubMed ID: 11728140
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of genetic insights into mendelian disease on cardiovascular clinical practice.
    Kim L; Devereux RB; Basson CT
    Circulation; 2011 Feb; 123(5):544-50. PubMed ID: 21300962
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetics of cardiovascular disease.
    Prog Med Genet; 1983; 5():1-423. PubMed ID: 6344141
    [No Abstract]   [Full Text] [Related]  

  • 40. Common mutations and polymorphisms predicting adverse cardiovascular events: current view.
    Visvikis-Siest S; Stathopoulou MG; Ndiaye NC
    Pharmacogenomics; 2012 Dec; 13(16):1875-8. PubMed ID: 23215878
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.